Cargando…
Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
Prostaglandin E2 (PGE2), a derivative of arachidonic acid, has been identified as a tumorigenic factor in many cancers in recent studies. Prostaglandin E synthase 2 (PTGES2) is an enzyme that in humans is encoded by the PTGES2 gene located on chromosome 9, and it synthesizes PGE2 in human cells. In...
Autores principales: | Ke, Jieqi, Yang, Yixia, Che, Qi, Jiang, Feizhou, Wang, Huihui, Chen, Zheng, Zhu, Minjiao, Tong, Huan, Zhang, Huilin, Yan, Xiaofang, Wang, Xiaojun, Wang, Fangyuan, Liu, Yuan, Dai, Chenyun, Wan, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080328/ https://www.ncbi.nlm.nih.gov/pubmed/27230680 http://dx.doi.org/10.1007/s13277-016-5087-x |
Ejemplares similares
-
Changing prostaglandin E2 (PGE(2)) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE(2) receptor EP2 and EP4
por: Huang, Qingqing, et al.
Publicado: (2021) -
Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9
por: Yan, Xiaofang, et al.
Publicado: (2020) -
Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition
por: Chen, Zheng, et al.
Publicado: (2015) -
COX-2-PGE(2)-EPs in gynecological cancers
por: Ye, Yao, et al.
Publicado: (2020) -
Pharmacological modulation of prostaglandin E(2) (PGE(2)) EP receptors improves cardiomyocyte function under hyperglycemic conditions
por: Bosma, Karin J., et al.
Publicado: (2022)